Metropolis Healthcare Launches High-performance High-Risk HPV DNA Testing to Accelerate Cervical Cancer Screening Across India
Feb 06, 2025
Mumbai (Maharashtra) [India], February 6: Ameera Shah-led Metropolis Healthcare Limited, India's second-largest and most respected pathology laboratory chain, today announced its collaboration with Roche Diagnostics India and Neighbouring Markets to introduce the self-sampling human papillomavirus (HPV) DNA test for cervical cancer screening. The launch of this test aims to expand access to cervical cancer screening across India by addressing social and economic barriers, making early detection more convenient for women, including those in Tier 2, Tier 3, and Tier 4 towns.
Read More...
